The Iowa Senate bill alters a proposal that would have penalized administering gene-based vaccines including the COVID-19 ...
Pfizer CEO Albert Bourla said on Monday the drugmaker might move overseas manufacturing to its existing plants in the United ...
(Reuters) -Pfizer CEO Albert Bourla said on Monday the drugmaker might move overseas manufacturing to its existing plants in ...
Rosacea treatment is a marathon — not a sprint — and there’s a need for increased emphasis on a patient-centric approach to ...
Pfizer's Q4/24 results showed significant improvements, with total revenue up 21.9% YoY and adjusted diluted EPS increasing ...
"I was expecting him probably to win. It was very big win," Pfizer's CEO Albert Bourla said of President Donald Trump's ...
Eli Lilly also responded to the President's tariff warnings by investing $27 billion to construct four manufacturing ...
Pfizer CEO Albert Bourla on Monday said that the company might move overseas manufacturing to its existing plants in the ...
CEO Albert Bourla said on Monday that the drugmaker could move some of its overseas manufacturing to its U.S. plants if ...
As biopharma players continue to parse out what the second Trump administration means for the industry, Pfizer CEO Albert ...
Pfizer CEO Albert Bourla announced the possibility of shifting overseas manufacturing to U.S. plants. This response is due to ...
The US president has imposed a 10 per cent tariff across all Chinese imports into the US and proposed a 25 per cent levy on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results